CEFIDEROCOL SULFATE TOSYLATE

CEFIDEROCOL SULFATE TOSYLATE was reported 315 times

These side effects are most commonly reported by patients taking CEFIDEROCOL SULFATE TOSYLATE:

# Side effect Count
0 DEATH 71
1 DRUG RESISTANCE 31
2 TREATMENT FAILURE 27
3 OFF LABEL USE 26
4 ACUTE KIDNEY INJURY 23
5 PATHOGEN RESISTANCE 17
6 HEPATIC CYTOLYSIS 14
7 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14
8 INFECTION 13
9 CHOLESTASIS 12
10 CONDITION AGGRAVATED 11
11 SEPTIC SHOCK 11
12 ENCEPHALOPATHY 10
13 NO ADVERSE EVENT 10
14 CHROMATURIA 9
15 PNEUMONIA 9
16 SEPSIS 9
17 PRODUCT STORAGE ERROR 7
18 THROMBOCYTOPENIA 7
19 DRUG EFFECT LESS THAN EXPECTED 6
20 DRUG INEFFECTIVE 6
21 INCORRECT PRODUCT ADMINISTRATION DURATION 6
22 MEDICATION ERROR 6
23 RASH 6
24 BRADYCARDIA 5
25 GENERAL PHYSICAL HEALTH DETERIORATION 5
26 GENERALISED TONIC-CLONIC SEIZURE 5
27 PYREXIA 5
28 CARDIAC ARREST 4
29 COVID-19 PNEUMONIA 4
30 DIARRHOEA 4
31 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4
32 EPILEPSY 4
33 HEPATIC FUNCTION ABNORMAL 4
34 RASH MACULO-PAPULAR 4
35 RESPIRATORY FAILURE 4
36 URTICARIA 4
37 ANAPHYLACTIC REACTION 3
38 BLOOD CREATININE INCREASED 3
39 CANDIDA INFECTION 3
40 DISEASE PROGRESSION 3
41 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3
42 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
43 ENCEPHALITIS 3
44 EOSINOPHILIA 3
45 LEUKOPENIA 3
46 NAUSEA 3
47 OVERDOSE 3
48 PRESCRIBED OVERDOSE 3
49 RENAL IMPAIRMENT 3
50 STATUS EPILEPTICUS 3
51 TUBULOINTERSTITIAL NEPHRITIS 3
52 VASCULAR DEVICE OCCLUSION 3
53 VOMITING 3
54 ACUTE MYELOID LEUKAEMIA 2
55 ACUTE RESPIRATORY DISTRESS SYNDROME 2
56 ALANINE AMINOTRANSFERASE INCREASED 2
57 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 2
58 ARTHRALGIA 2
59 BACTERAEMIA 2
60 CARDIO-RESPIRATORY ARREST 2
61 CHEST PAIN 2
62 CLOSTRIDIUM DIFFICILE COLITIS 2
63 COAGULOPATHY 2
64 CONSTIPATION 2
65 COUGH 2
66 DECREASED APPETITE 2
67 DRY MOUTH 2
68 DRY SKIN 2
69 DYSENTERY 2
70 EMBOLISM 2
71 FATIGUE 2
72 FEBRILE NEUTROPENIA 2
73 FLUSHING 2
74 FUNGAL INFECTION 2
75 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2
76 HAEMOPTYSIS 2
77 HAIR COLOUR CHANGES 2
78 HEADACHE 2
79 HEPATOTOXICITY 2
80 HYPERBILIRUBINAEMIA 2
81 HYPERSENSITIVITY 2
82 INSOMNIA 2
83 LABORATORY TEST ABNORMAL 2
84 LIPASE INCREASED 2
85 LIVER ABSCESS 2
86 LIVER FUNCTION TEST INCREASED 2
87 LUNG ABSCESS 2
88 MEDIASTINITIS 2
89 MUCOSAL INFLAMMATION 2
90 MYOCLONUS 2
91 MYOPATHY 2
92 NASOPHARYNGITIS 2
93 PEPTIC ULCER HAEMORRHAGE 2
94 RASH ERYTHEMATOUS 2
95 SKIN BURNING SENSATION 2
96 SKIN EXFOLIATION 2
97 STEVENS-JOHNSON SYNDROME 2
98 STOMATITIS 2
99 SYSTEMIC CANDIDA 2
100 TONGUE ERYTHEMA 2
101 TONGUE ROUGH 2
102 WEIGHT DECREASED 2
103 ABDOMINAL INFECTION 1
104 ACINETOBACTER BACTERAEMIA 1
105 ACINETOBACTER SEPSIS 1
106 ACUTE RESPIRATORY FAILURE 1
107 ADVERSE DRUG REACTION 1
108 AGRANULOCYTOSIS 1
109 ALTERED STATE OF CONSCIOUSNESS 1
110 AMPUTATION 1
111 ANGIOEDEMA 1
112 ANURIA 1
113 AORTIC ANEURYSM RUPTURE 1
114 ASPARTATE AMINOTRANSFERASE INCREASED 1
115 ATRIOVENTRICULAR BLOCK COMPLETE 1
116 BACK PAIN 1
117 BACTERIAL INFECTION 1
118 BILE DUCT NECROSIS 1
119 BLADDER SPASM 1
120 BLINDNESS 1
121 BLOOD BILIRUBIN INCREASED 1
122 BLOOD UREA INCREASED 1
123 BLOOD URINE 1
124 BRONCHOSPASM 1
125 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1
126 BURKHOLDERIA INFECTION 1
127 C-REACTIVE PROTEIN INCREASED 1
128 CEREBRAL INFARCTION 1
129 CHILLS 1
130 CHOLANGITIS 1
131 CIRCULATORY COLLAPSE 1
132 CLOSTRIDIUM DIFFICILE INFECTION 1
133 COLITIS ISCHAEMIC 1
134 COVID-19 1
135 DEEP VEIN THROMBOSIS 1
136 DEPRESSED MOOD 1
137 DERMATITIS CONTACT 1
138 DEVICE RELATED INFECTION 1
139 DEVICE RELATED SEPSIS 1
140 DISORIENTATION 1
141 DRUG ERUPTION 1
142 DRUG INTERACTION 1
143 DRUG-INDUCED LIVER INJURY 1
144 DYSPHAGIA 1
145 DYSPNOEA 1
146 EAR PAIN 1
147 ELECTROLYTE IMBALANCE 1
148 EOSINOPHIL COUNT INCREASED 1
149 EOSINOPHILIC PNEUMONIA 1
150 ERYTHEMA 1
151 EXCESSIVE GRANULATION TISSUE 1
152 FOURNIER^S GANGRENE 1
153 FUSARIUM INFECTION 1
154 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
155 GASTROINTESTINAL HAEMORRHAGE 1
156 HAEMATOLOGICAL MALIGNANCY 1
157 HAEMATURIA 1
158 HAEMODYNAMIC INSTABILITY 1
159 HAEMOLYTIC ANAEMIA 1
160 HAEMORRHAGIC CEREBRAL INFARCTION 1
161 HALLUCINATION, AUDITORY 1
162 HEPATIC ENZYME INCREASED 1
163 HEPATOSPLENIC CANDIDIASIS 1
164 HODGKIN^S DISEASE RECURRENT 1
165 HYPERHIDROSIS 1
166 HYPERNATRAEMIA 1
167 HYPERTENSION 1
168 HYPERVOLAEMIA 1
169 HYPONATRAEMIA 1
170 HYPOXIA 1
171 ILLNESS 1
172 INFECTION REACTIVATION 1
173 INFECTIOUS PLEURAL EFFUSION 1
174 INTENTIONAL OVERDOSE 1
175 KLEBSIELLA INFECTION 1
176 LACTIC ACIDOSIS 1
177 LARYNGEAL OEDEMA 1
178 LEUKAEMIA RECURRENT 1
179 LEUKOCYTOSIS 1
180 LIVER DISORDER 1
181 LOSS OF CONSCIOUSNESS 1
182 LUNG ADENOCARCINOMA 1
183 LUNG DISORDER 1
184 MECHANICAL VENTILATION 1
185 MENINGITIS CANDIDA 1
186 METAPLASIA 1
187 METASTASES TO LUNG 1
188 MOUTH HAEMORRHAGE 1
189 MOUTH ULCERATION 1
190 MUSCLE ATROPHY 1
191 NEOPLASM PROGRESSION 1
192 NERVOUS SYSTEM DISORDER 1
193 NEURALGIA 1
194 NEUTROPENIA 1
195 NEUTROPHIL COUNT DECREASED 1
196 NIGHT SWEATS 1
197 NOSOCOMIAL INFECTION 1
198 OEDEMA 1
199 OLIGURIA 1
200 ORGAN FAILURE 1
201 PARAESTHESIA 1
202 PARTIAL SEIZURES 1
203 PLATELET COUNT DECREASED 1
204 POST PROCEDURAL COMPLICATION 1
205 POST PROCEDURAL INFECTION 1
206 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1
207 PRESCRIBED UNDERDOSE 1
208 PRODUCT DISPENSING ISSUE 1
209 PRODUCT DOSE OMISSION ISSUE 1
210 PRODUCT LABEL ISSUE 1
211 PRODUCT STORAGE ISSUE 1
212 PSEUDOMONAL SEPSIS 1
213 PSEUDOMONAS INFECTION 1
214 PULMONARY MUCORMYCOSIS 1
215 PULMONARY RENAL SYNDROME 1
216 REFUSAL OF TREATMENT BY PATIENT 1
217 RENAL FAILURE 1
218 RENAL TUBULAR DISORDER 1
219 RENAL TUBULAR NECROSIS 1
220 RESPIRATORY DISTRESS 1
221 RETCHING 1
222 RHABDOMYOLYSIS 1
223 RIB DEFORMITY 1
224 RIB FRACTURE 1
225 SICKLE CELL DISEASE 1
226 SOMNOLENCE 1
227 SPUTUM PURULENT 1
228 STAPHYLOCOCCAL INFECTION 1
229 STAPHYLOCOCCAL SEPSIS 1
230 SUBARACHNOID HAEMORRHAGE 1
231 TACHYCARDIA 1
232 THERAPY CESSATION 1
233 THERAPY NON-RESPONDER 1
234 THERAPY PARTIAL RESPONDER 1
235 THROAT IRRITATION 1
236 TOXIC ENCEPHALOPATHY 1
237 TRACHEAL INFLAMMATION 1
238 TREATMENT DELAYED 1
239 TUMOUR LYSIS SYNDROME 1
240 TYPE I HYPERSENSITIVITY 1
241 URINARY TRACT INFECTION 1
242 URINE ABNORMALITY 1
243 VANISHING BILE DUCT SYNDROME 1
244 WHITE BLOOD CELL COUNT INCREASED 1